BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2667746)

  • 1. A randomized trial of adjuvant progestagen in early endometrial cancer.
    Vergote I; Kjørstad K; Abeler V; Kolstad P
    Cancer; 1989 Sep; 64(5):1011-6. PubMed ID: 2667746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1985 Feb; 20(2):139-55. PubMed ID: 3972284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial.
    Urbański K; Karolewski K; Kojs Z; Klimek M; Dyba T
    Eur J Gynaecol Oncol; 1993; 14 Suppl():98-104. PubMed ID: 8200383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
    Onsrud M
    Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
    Bokhman IaV; Stoliarova IV; Gastev AIu
    Vopr Onkol; 1987; 33(4):49-52. PubMed ID: 3296435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestagens for endometrial cancer.
    Martin-Hirsch P L; Jarvis G; Kitchener H; Lilford R
    Cochrane Database Syst Rev; 2000; (2):CD001040. PubMed ID: 10796737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].
    Bochmann JW
    Zentralbl Gynakol; 1981; 103(21):1289-93. PubMed ID: 7324631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of progestational agents in treatment of endometrial carcinoma.
    Podratz KC; O'Brien PC; Malkasian GD; Decker DG; Jefferies JA; Edmonson JH
    Obstet Gynecol; 1985 Jul; 66(1):106-10. PubMed ID: 4011061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of hydroxyprogesterone caproate to maintain pregnancy in ovariectomised mares.
    McKinnon AO; Tarrida del Marmol Figueroa S; Nobelius AM; Hyland JH; Vasey JR
    Equine Vet J; 1993 Mar; 25(2):158-60. PubMed ID: 8467776
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 17-alpha-hydroxyprogesterone 17-n-caproate on urine flow.
    Brooks ME; Braf ZF
    Urology; 1981 May; 17(5):488-91. PubMed ID: 6165131
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum lipids and lipoproteins in patients with endometrial carcinoma receiving adjuvant treatment with hydroxyprogesterone caproate.
    Onsrud M
    Acta Obstet Gynecol Scand; 1985; 64(2):179-82. PubMed ID: 3885671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients.
    Aalders JG; Abeler V; Kolstad P
    Gynecol Oncol; 1984 Jan; 17(1):64-74. PubMed ID: 6693053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer].
    Shvedova LA; Botnar' ER; Shendereva TS; Volostnykh LV; Chernyĭ AP
    Vopr Onkol; 1984; 30(3):40-4. PubMed ID: 6710947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
    Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS
    Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650
    [No Abstract]   [Full Text] [Related]  

  • 17. Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal function.
    Onsrud M; Paus E; Haug E; Kjørstad K
    Acta Obstet Gynecol Scand; 1985; 64(6):519-23. PubMed ID: 2932883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy and endocrine therapy of endometrial carcinoma].
    Kanuma T; Matsuzawa M
    Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Shtofmakher IA
    Vopr Onkol; 1989; 35(9):1063-7. PubMed ID: 2815695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.